Sarina Madhavan

Articles

OPINION  |  COLUMNS

Is Azar the antidote to the opioid crisis?

By Sarina Madhavan | December 4, 2017

President Trump nominated former pharmaceutical company CEO Alex Azar for secretary of the US Department of Health and Human Services. If confirmed, Azar would be tasked with implementing many of the public health solutions to the opioid crisis in the short and long term. But this widespread power could be uniquely dangerous in the hands of an ex-industry executive.

---

OPINION  |  COLUMNS

Under the hood: Duke's pre-med fraternity

By Sarina Madhavan | November 2, 2017

I ventured to learn more about PhiDE’s potential role on campus and of the hurdles that this new group expects to face while integrating into the Duke community.

---

OPINION  |  COLUMNS

Dos and don'ts of undergraduate research

By Sarina Madhavan | September 21, 2017

How do undergraduate students get stuck toiling on a project they don’t even care about? Can “true love” ever exist between Duke undergrads and Duke labs?

---

OPINION  |  COLUMNS

A category four misunderstanding

By Sarina Madhavan | September 11, 2017

So, particularly as the American public searches for someone to blame for these consecutive, devastating events, be on the lookout for superficial analyses and unwarranted finger-pointing. Often, the way we frame science drives the narrative more than the science itself.

---

OPINION  |  COLUMNS

Trumpcare still has a pulse

By Sarina Madhavan | June 19, 2017

Cutting sick people who need it most from their access to medical care is like amputating an arm for a systemic infection.

More Articles